BioSight
Companies
MARAVAI LIFESCIENCES HOLDINGS, INC. logo

MRVI

NASDAQSAN DIEGO, CA
MARAVAI LIFESCIENCES HOLDINGS, INC.

Maravai LifeSciences is a life sciences company providing critical products and services to biopharmaceutical companies, emerging biotech firms, research institutions, and diagnostics companies across the drug development continuum. Operating through two segments, TriLink and Cygnus, Maravai offers complex nucleic acids including mRNA, oligonucleotides, and specialty enzymes for therapeutic, vaccine, and diagnostic applications, along with proprietary technologies such as CleanCap mRNA capping and ModTail poly(A) tail modification to support preclinical, clinical, and commercial development stages. Cygnus provides biologics safety testing products and services including host cell protein ELISA kits and impurity detection assays to support biopharmaceutical manufacturing.

Price history not yet available for MRVI.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar